Xeris Biopharma Holdings, Inc.

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $37.6m $67.3m $122.0m $67.4m $71.6m $111.0m
Short-term Investments $96.2m $35.2m $0 $5.0m $0
Inventory, Net $8.4m $18.1m $24.7m $38.8m $48.2m $68.7m
Assets, Current $152.2m $142.6m $186.8m $156.3m $167.7m $240.3m
Property, Plant and Equipment, Net $6.7m $6.6m $5.5m $6.0m $5.6m $4.9m
Goodwill $0 $22.9m $22.9m $22.9m $22.9m $22.9m
Intangible Assets, Net (Excluding Goodwill) $0 $131.4m $120.6m $109.8m $98.9m $88.1m
Operating Lease, Right-of-Use Asset $0 $4.0m $23.2m $22.6m $22.1m
Other Assets, Noncurrent $232k $829k $4.7m $4.5m $5.4m $5.2m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $6.9m $17.5m $30.8m $39.2m $40.4m $51.0m
Accrued Liabilities, Current $15.9m $49.1m $36.8m $23.5m $27.7m $33.2m
Assets $159.2m $304.4m $344.5m $322.6m $323.1m $383.5m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $0 $1.6m $3.5m $6.1m $6.2m
Accounts Payable, Current $3.1m $8.9m $4.6m $11.6m $2.3m $3.1m
Operating Lease, Liability, Noncurrent $0 $9.4m $34.8m $33.3m $31.5m
Long-term Debt, Excluding Current Maturities $87.0m $88.1m $187.1m $190.9m $217.0m $220.3m
Long-term Debt, Current Maturities $87.0m $88.1m $187.1m $190.9m $15.1m $0
Liabilities, Current $28.2m $79.0m $73.6m $95.2m $100.4m $109.6m
Deferred Income Tax Liabilities, Net $0 $4.9m $3.5m $2.3m $0
Other Liabilities, Noncurrent $3.5m $1.7m $31k $4.8m $2.0m $8.4m
Deferred Tax Liabilities, Net $0 $4.9m $3.5m $2.3m $0 $0
Liabilities $125.4m $209.1m $299.3m $329.4m $352.7m $369.8m
Stockholders’ equity:
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0
Common Stock, Value, Issued $6k $13k $14k $14k $15k $17k
Additional Paid in Capital $371.1m $555.4m $600.0m $610.3m $642.3m $685.0m
Retained Earnings (Accumulated Deficit) ($337.4m) ($460.1m) ($554.8m) ($617.0m) ($671.9m) ($671.3m)
Accumulated Other Comprehensive Income (Loss), Net of Tax $6k ($31k) ($23k) ($25k) ($25k) ($25k)
Stockholders' Equity Attributable to Parent $33.8m $95.2m $45.2m ($6.8m) ($29.6m) $13.7m
Liabilities and Equity $159.2m $304.4m $344.5m $322.6m $323.1m $383.5m